Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.
about
Dysregulation of antiviral helicase pathways in systemic lupus erythematosusAdvances in lupus geneticsGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Expression of Interferon-γ Receptor Genes in Peripheral Blood Mononuclear Cells Is Associated With Rheumatoid Arthritis and Its Radiographic Severity in African Americans.Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populationsImmunogenetics of systemic lupus erythematosus: A comprehensive review.The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.Drugs in early clinical development for Systemic Lupus Erythematosus.Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.Systemic lupus erythematosus biomarkers: the challenging quest.Type I interferon in human autoimmunity.Autoimmune disease genetics 2013A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).Pathways of impending disease flare in African-American systemic lupus erythematosus patients.A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.
P2860
Q21129494-45D0BE0F-A1BF-40C1-A007-FFCE9D41D348Q28088718-BE146447-5D4A-4106-8F54-9708F25E258BQ35008001-FA8D00FA-2F92-4049-AC08-4EB365B84388Q35554384-C745791E-BFA3-489A-A5CD-A2A27849BAA1Q35688808-399762DF-4683-44F1-83AB-4DC661833384Q36236807-BEBBA2C8-98BD-464C-99D5-8BAA3B89922BQ36338717-D72C84C2-101A-422A-8AD5-413C270C9F7BQ37324772-D8CF04C1-FF71-47CD-BB4D-4FE4C7FEF3F0Q37673362-CC299C54-D2B2-418B-B5A8-F601AC6E6DE5Q39053118-9D3F53FF-9424-4CC1-9155-11E2E1B31273Q41452537-827717C2-DAAF-49A5-8653-9E6DD88D29B2Q42825717-0EE7DA99-F842-4162-9C6A-29F49B1C6153Q46055629-7E7DF273-01D0-45F6-A0B9-8D59040E34D7Q50910971-9E426C27-617F-4551-BF59-4034817B388FQ51714471-F341BA3F-9A99-4B56-872B-6A7941D94A72Q55409997-3DA4D710-578E-42E0-AB81-C60EB40C4136
P2860
Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of the Interferon P ...... uropean-American SLE Patients.
@en
Activation of the Interferon P ...... uropean-American SLE Patients.
@nl
type
label
Activation of the Interferon P ...... uropean-American SLE Patients.
@en
Activation of the Interferon P ...... uropean-American SLE Patients.
@nl
prefLabel
Activation of the Interferon P ...... uropean-American SLE Patients.
@en
Activation of the Interferon P ...... uropean-American SLE Patients.
@nl
P2093
P2860
P356
P1476
Activation of the Interferon P ...... uropean-American SLE Patients.
@en
P2093
Elizabeth Rosenzweig
Yelena Koldobskaya
P2860
P356
10.3389/FIMMU.2013.00309
P577
2013-10-01T00:00:00Z